These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 1646086

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The magnitude and specificity of influenza A virus-specific cytotoxic T-lymphocyte responses in humans is related to HLA-A and -B phenotype.
    Boon AC, de Mutsert G, Graus YM, Fouchier RA, Sintnicolaas K, Osterhaus AD, Rimmelzwaan GF.
    J Virol; 2002 Jan; 76(2):582-90. PubMed ID: 11752149
    [Abstract] [Full Text] [Related]

  • 23. Complete regression of posttransplant lymphoproliferative disease using partially HLA-matched Epstein Barr virus-specific cytotoxic T cells.
    Haque T, Taylor C, Wilkie GM, Murad P, Amlot PL, Beath S, McKiernan PJ, Crawford DH.
    Transplantation; 2001 Oct 27; 72(8):1399-402. PubMed ID: 11685111
    [Abstract] [Full Text] [Related]

  • 24. Increased frequency of antigen-specific CD8(+) cytotoxic T lymphocytes infiltrating an Epstein-Barr virus-associated gastric carcinoma.
    Kuzushima K, Nakamura S, Nakamura T, Yamamura Y, Yokoyama N, Fujita M, Kiyono T, Tsurumi T.
    J Clin Invest; 1999 Jul 27; 104(2):163-71. PubMed ID: 10411545
    [Abstract] [Full Text] [Related]

  • 25. Identification of type B-specific and cross-reactive cytotoxic T-lymphocyte responses to Epstein-Barr virus.
    Kerr BM, Kienzle N, Burrows JM, Cross S, Silins SL, Buck M, Benson EM, Coupar B, Moss DJ, Sculley TB.
    J Virol; 1996 Dec 27; 70(12):8858-64. PubMed ID: 8971014
    [Abstract] [Full Text] [Related]

  • 26. Impaired cytotoxic T lymphocyte response to Epstein-Barr virus-infected NK cells in patients with severe chronic active EBV infection.
    Tsuge I, Morishima T, Kimura H, Kuzushima K, Matsuoka H.
    J Med Virol; 2001 Jun 27; 64(2):141-8. PubMed ID: 11360246
    [Abstract] [Full Text] [Related]

  • 27. Analysis of cytotoxic T cell precursor frequencies directed against individual HLA-A and -B alloantigens.
    Zhang L, Li SG, Vandekerckhove B, Termijtelen A, Van Rood JJ, Claas FH.
    J Immunol Methods; 1989 Jul 06; 121(1):39-45. PubMed ID: 2787821
    [Abstract] [Full Text] [Related]

  • 28. Quantitative and functional diversity of cross-reactive EBV-specific CD8+ T cells in a longitudinal study cohort of lung transplant recipients.
    Mifsud NA, Nguyen TH, Tait BD, Kotsimbos TC.
    Transplantation; 2010 Dec 27; 90(12):1439-49. PubMed ID: 21042237
    [Abstract] [Full Text] [Related]

  • 29. The effect of individual HLA-A and -B mismatches on the generation of cytotoxic T lymphocyte precursors.
    Zhang L, van Bree S, van Rood JJ, Claas FH.
    Transplantation; 1990 Dec 27; 50(6):1008-10. PubMed ID: 2256142
    [Abstract] [Full Text] [Related]

  • 30. Cytotoxic T lymphocytes against HLA-B antigens are less naive than cytotoxic T lymphocytes against HLA-A antigens.
    Roelen DL, van Bree SP, van Beelen E, Schanz U, van Rood JJ, Claas FH.
    Transplantation; 1994 Feb 27; 57(3):446-50. PubMed ID: 8108881
    [Abstract] [Full Text] [Related]

  • 31. Parainfluenza type 1 virus-infected cells are killed by both CD8+ and CD4+ cytotoxic T cell precursors.
    Slobod KS, Allan JE.
    Clin Exp Immunol; 1993 Sep 27; 93(3):363-9. PubMed ID: 8396514
    [Abstract] [Full Text] [Related]

  • 32. The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantation.
    Lucas KG, Small TN, Heller G, Dupont B, O'Reilly RJ.
    Blood; 1996 Mar 15; 87(6):2594-603. PubMed ID: 8630428
    [Abstract] [Full Text] [Related]

  • 33. Role of different lymphocyte subsets in human anti-viral T cell cultures.
    Gomez A, Bourgault I, Gomard E, Picard F, Levy JP.
    Cell Immunol; 1989 Feb 15; 118(2):312-27. PubMed ID: 2562930
    [Abstract] [Full Text] [Related]

  • 34. Analysis of T cell responses in liver allograft recipients. Evidence for deletion of donor-specific cytotoxic T cells in the peripheral circulation.
    Mathew JM, Marsh JW, Susskind B, Mohanakumar T.
    J Clin Invest; 1993 Mar 15; 91(3):900-6. PubMed ID: 8450068
    [Abstract] [Full Text] [Related]

  • 35. [Ex vivo inducing cultured Epstein-Barr virus specific cytotoxic T lymphocytes and evaluation of their killing effect].
    Chen GH, Gu B, Chen F, Wang Y, Qiao M, Liu HW, Feng YF, Dai LJ, Zhu ZL, Wu DP.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec 15; 21(6):1597-601. PubMed ID: 24370055
    [Abstract] [Full Text] [Related]

  • 36. Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2r gamma(null) humanized mice.
    Shultz LD, Saito Y, Najima Y, Tanaka S, Ochi T, Tomizawa M, Doi T, Sone A, Suzuki N, Fujiwara H, Yasukawa M, Ishikawa F.
    Proc Natl Acad Sci U S A; 2010 Jul 20; 107(29):13022-7. PubMed ID: 20615947
    [Abstract] [Full Text] [Related]

  • 37. Human immunodeficiency virus type 1 (HIV-1)--and Epstein-Barr virus--specific cytotoxic T lymphocyte precursors exhibit different kinetics in HIV-1--infected persons.
    Geretti AM, Dings ME, van Els CA, van Baalen CA, Wijnholds FJ, Borleffs JC, Osterhaus AD.
    J Infect Dis; 1996 Jul 20; 174(1):34-45. PubMed ID: 8656011
    [Abstract] [Full Text] [Related]

  • 38. Inhibition of Epstein-Barr virus (EBV)-specific CD8+ cytotoxic T lymphocyte (CTL) activity by soluble HLA class I in vitro.
    Gansuvd B, Hagihara M, Munkhbat B, Kanai N, Morita N, Munkhtuvshin N, Chargui J, Kato S, Hotta T, Tsuji K.
    Clin Exp Immunol; 2000 Jan 20; 119(1):107-14. PubMed ID: 10606971
    [Abstract] [Full Text] [Related]

  • 39. Adoptive transfer of autologous Epstein-Barr virus-specific cytotoxic T cells for nasopharyngeal carcinoma.
    Chua D, Huang J, Zheng B, Lau SY, Luk W, Kwong DL, Sham JS, Moss D, Yuen KY, Im SW, Ng MH.
    Int J Cancer; 2001 Oct 01; 94(1):73-80. PubMed ID: 11668481
    [Abstract] [Full Text] [Related]

  • 40. Permissible and immunogenic HLA-A mismatches: cytotoxic T-cell precursor frequencies reflect graft survival data.
    Roelen DL, Stobbe I, Young NT, van Bree SP, Doxiadis II, Oudshoorn M, Morris PJ, Wood KJ, Claas FH.
    Hum Immunol; 2001 Jul 01; 62(7):661-7. PubMed ID: 11423171
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.